21 January 09:00
Karolinska Institutet Science Park (KISP) and CiToxLAB hosts a workshop focusing on preclinical drug development.
Program:
09:00 Preclinical Profiling and other Attrition Reducing Technologies
Daniele Pezzetta, Accelera (Italy)
ADME screening technologies, In vitro cross species metabolism, Bioanalysis
09:30 Exploratory Preclinical Development
Urban Höglund, CEO Adlego Biomedical (Sweden)
Preclinical screening strategies, Pharmacokinetics, Imaging techniques, Models of
efficacy for different compounds
10:00 Coffee break
10:30 Regulatory Preclinical Development
Peter Glerup, Chief Veterinary Surgeon and Director Business Development,
CiToxLAB Scantox (Denmark)
Guideline requirements for biopharmaceuticals, Anti-cancer agents, Biopharmaceuticals
and vaccines, Species selection, Experimental designs, Timing, Practical considerations,
Animal Welfare and Good Laboratory Practice (GLP)
11:00 A Regulator´s Perspective on Preclinical Drug Development
Anna Franzén, The Innovation Office, External Relations and Innovation Support,
Medical Products Agency (Sweden)
Important regulation of Drug Development, When to seek scientific advice?
11:30 Panel discussion and Round-up
All speakers
12:00-13:00 Networking Lunch - kindly provided by CiToxLAB
When: January 21, 2015 at 9:00-13:00
Where: Karolinska Institutet Science Park, Tomtebodavägen 23a, Solna
Registration: info@kisciencepark.se
Registrering
KISP_PreclinDrugDev_21Jan2015.pdf
(284.77 KB)